Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Atea Pharmaceuticals Inc shares valued at $218,819 were sold by Sommadossi Jean-Pierre on Feb 01 ’24. At $3.85 per share, Sommadossi Jean-Pierre sold 56,910 shares. The insider’s holdings dropped to 116,557 shares worth approximately $0.45 million following the completion of this transaction.
Also, Horga Maria Arantxa sold 15,870 shares, netting a total of over 60,963 in proceeds. Following the sale of shares at $3.84 each, the insider now holds 25,664 shares.
Before that, Corcoran Andrea had sold 15,843 shares from its account. In a trade valued at $60,915, the insider traded Atea Pharmaceuticals Inc shares for $3.84 each. Upon closing the transaction, the insider’s holdings decreased to 15,843 shares, worth approximately $2.58 million.
As published in a research note from JP Morgan on August 10, 2023, Atea Pharmaceuticals Inc [AVIR] has been rated down from a Neutral to an Underweight. Analysts at Morgan Stanley downgraded the stock from ‘”an Equal-weight”‘ to ‘”an Underweight”‘ outlook in a report released in early January. As of November 18, 2021, SVB Leerink has decreased its “an Outperform” rating to a “Mkt perform” for AVIR. Earlier on October 20, 2021, JP Morgan downgraded its rating. Their new recommendation was “a Neutral” for AVIR stock which previously was a “an Overweight”.
Analyzing AVIR Stock Performance
During the last five days, there has been a surge of approximately 4.05%. Over the course of the year, Atea Pharmaceuticals Inc shares have jumped approximately 26.23%. Shares of the company reached a 52-week high of $4.60 on 02/29/24 and a 52-week low of $3.01 on 01/05/24. A 50-day SMA is recorded $3.94, while a 200-day SMA reached $3.47. Nevertheless, trading volume fell to 0.41 million shares from 0.23 million shares the previous day.
Support And Resistance Levels for Atea Pharmaceuticals Inc (AVIR)
According to the 24-hour chart, there is a support level at 3.73, which, if violated, would cause prices to drop to 3.62. In the upper region, resistance lies at 3.95. The next price resistance is at 4.05. RSI (Relative Strength Index) is 53.83 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.03, which suggests the price will decrease in the coming days. Percent R is at 30.07%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
